HLA-DRB1 and myeloid sarcoma: There is now strong evidence that EBV infection plays a major role in MS pathogenesis (Bjornevik et al., 2022), acting synergistically with HLA-DRB1*15 to increase the likelihood of developing MS (Nielsen et al., 2009).